Pfizer Q1: Headwinds And Tailwinds From COVID-19

 
• By Jessica Merrill
  
SC2004_Pfizer_286009616_1200.jpg
Pfizer's biopharmaceutical revenues held up in the first quarter • Source: Shutterstock

More from Earnings

More from Business